Grimstad T, Carlsen A, Kvaløy JT, Bolstad N, Warren DJ, Aabakken L, Lundin KEA, Karlsen L, Steinsbø Ø, Omdal R (2025)
Fatigue in Inflammatory Bowel Disease: No Effect of Serum Concentrations of Infliximab, Adalimumab or Anti-Drug Antibodies During Maintenance Therapy
Scand J Immunol, 101 (5), e70029
DOI 10.1111/sji.70029, PubMed 40289444

Hansen SH, Maseng MG, Grännö O, Vestergaard MV, Bang C, Olsen BC, Lund C, Olbjørn C, Løvlund EE, Vikskjold FB, Huppertz-Hauss G, Perminow G, Yassin H, Valeur J, Aass Holten KI, Henriksen M, Bengtson MB, Ricanek P, Opheim R, Boyar R, Torp R, Frigstad SO, Aabrekk TB, Detlie TE, Kristensen VA et al. (2025)
Fecal Microbiome Reflects Disease State and Prognosis in Inflammatory Bowel Disease in an Adult Population-Based Inception Cohort
Inflamm Bowel Dis (in press)
DOI 10.1093/ibd/izaf060, PubMed 40285477

Dahl TB, Aftab F, Prebensen C, Berdal JE, Ueland T, Barratt-Due A, Riise AMD, Ueland PM, Hov JR, Trøseid M, Aukrust P, Gregersen I, Myhre PL, Omland T, Halvorsen B (2025)
Imidazole propionate is increased in severe COVID-19 and correlates with cardiac involvement
J Infect, 106494 (in press)
DOI 10.1016/j.jinf.2025.106494, PubMed 40280497

Lorentsen JLL, Brunborg C, Aasebø AT, Valeur J, Haavardsholm EA, Molberg Ø, Palm Ø, Lerang K (2025)
Incidence and prevalence of Behçet's disease in Oslo Norway: a two-decade population-based analysis
Rheumatology (Oxford) (in press)
DOI 10.1093/rheumatology/keaf224, PubMed 40279276